rss
Evid Based Med 10:120 doi:10.1136/ebm.10.4.120
  • Therapeutics

Review: naltrexone reduces alcohol consumption (in the short-term) in patients with alcohol dependence

Naltrexone v placebo in alcohol dependence at ⩽3 months*

Outcomes at ⩽3 months Number of trials (n) Weighted event rates RRR (95% CI) NNT (CI)
Naltrexone Control
*Abbreviations defined in glossary; weighted event rates, RRR, and CI calculated from data in article using a random effects model.
Had a relapse or returned to heavy drinking 7 (822) 28% 43% 36% (18 to 49) 7 (5 to 13)
Returned to drinking 10 (1014) 55% 65% 13% (0 to 24) 10 (6 to 100)
Discontinued the medication 18 (1776) 35% 43% 18% (3 to 30) 13 (7 to 100)

This Article

Latest from the blog

Latest from the blog


Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.